Trials / Unknown
UnknownNCT02733484
Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity
Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity: a Randomized, Double-blind Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the probiotics will be effective in the treatment of obesity
Detailed description
This study aims to evaluate the effect of probiotics on the improvement of glucose and lipid metabolism, as well as the gut microbiota.Baseline, 1 month and 3 months data will be collected and put into analysis to provide some suggestions on the probiotics use in the clinical practice for obesity patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotics | the patients in this arm will receive probiotics with a dose for 2g/d for 3 months. |
| DIETARY_SUPPLEMENT | Placebo | the patients in this arm will receive placebo intervention |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-04-11
- Last updated
- 2017-03-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02733484. Inclusion in this directory is not an endorsement.